Endpoint Clinical and THREAD have partnered to provide two-way integration for eConsent, screening, and randomization, allowing for the automation of underlying workflows across the two platforms. The interfacing of systems has a special impact on sites because it eliminates the need for duplicate data entry.
Fremont, CA: endpoint Clinical, the global leader in interactive response technology (IRT®) for clinical trials, and THREAD, leading technology and service provider enabling decentralized clinical trials (DCT), has declared a collaboration to provide sponsors and sites with a solution that simplifies DCT operations and shortens research study timelines.
"Adoption of DCT technologies that are capable of not only performing individually as best-in-class solutions but are also designed and engineered to be at optimal performance in an integrated clinical data mesh are the key to meeting demands and leading in the rapidly changing landscape of clinical trials," stated Brad Cottreau, Vice President of Global Sales at endpoint Clinical.
This ecosystem approach fully realizes the potential of critical functions like telehealth visits and direct-to-patient/home health shipping of study drugs, all while maintaining mission-critical goals like high patient engagement, compliance, and retention.
Endpoint Clinical and THREAD have partnered to provide two-way integration for eConsent, screening, and randomization, allowing for the automation of underlying workflows across the two platforms. The interfacing of systems has a special impact on sites because it eliminates the need for duplicate data entry. Furthermore, this integrated approach streamlines operations like subject creation, assessments, screening, randomization (including dispensing), and subject treatment visits. The platforms' two-way communication allows for data-driven, rapid feedback that can inform strategies for clinical operations, patient recruitment, supply procurement, and data management. As a consequence, the data is cleaner, and the study is completed faster.
